253796-85-9

Upstream product

• 105-36-2 ethyl bromoacetate 
• 10185-68-9 4-(5-methyl-1,2,4-oxadiazol-3-yl)-aniline 

Downstream Products

• 211915-06-9 dabigatran etexilate 
• 1411034-23-5 ethyl {[1-methyl-2-({[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]amino}methyl)-1H-benzimidazol-5-yl]carbonyl}-N-(pyridine-2-yl)-β-alaninate 
• 1411034-28-0 ethyl N-{[1-methyl-2-({[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]amino}methyl)-1H-benzimidazol-5-yl]carbonyl}-N-(pyridin-2-yl)-β-alaninate oxalate salt 

Relevant academic research and scientific papers

PHARMACEUTICAL INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF

The present invention relates to a process for the preparation of dabigatran etexilate of the formula or pharmaceutically accepted salts thereof.

PROCESS FOR THE MANUFACTURE OF DABIGATRAN ETEXILATE AND INTERMEDIATES THEREOF

The present invention relates to a process for the preparation of dabigatran etexilate of the formula (1) or the pharmaceutically accepted salts thereof.